Barriers and Facilitators to Genetic Testing for Familial Hypercholesterolemia in the United States: A Review

Barriers and Facilitators to Genetic Testing for Familial Hypercholesterolemia in the United States: A Review

Familial Hypercholesterolemia (FH) is an underdiagnosed condition in the United States (US) and globally, affecting an estimated 1/250 individuals. It is a genetic risk factor for premature cardiovascular disease and is responsible for an estimated 600,000 to 1.2 million preventable vascular events....

Full description

Bibliographic Details
Main Authors: Rachele M. Hendricks-Sturrup, Kathleen M. Mazor, Amy C. Sturm, Christine Y. Lu
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Journal of Personalized Medicine
Subjects:
familial hypercholesterolemia
genetic testing
implementation framework
barriers and facilitators
genomic medicine
Online Access:https://www.mdpi.com/2075-4426/9/3/32

Similar Items

Similar Items